Takeover

Acquirers

Cardurion Pharmaceuticals, Inc.

Targets
1
Filings
2
Median premium
—
First filing
Sep 23, 2022
Latest filing
Oct 7, 2022

Targets

CompanyTakeover scoreFilingsLatest
ELVNEnliven Therapeutics, Inc.42Oct 7, 2022

Deal filings

FiledCompanyFormPricePremium
Oct 7, 2022ELVNEnliven Therapeutics, Inc.DEFM14A$34750000.00—
Sep 23, 2022ELVNEnliven Therapeutics, Inc.PREM14A$34750000.00—